Physician profile
Aaron Wey
NPI 1497175210
$8,272.40
in general payments reported to CMS, 2019-2025
15 companies · $1,734 in 2025
The $1,734 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.41 · 2020: $1,014 · 2021: $193 · 2022: $1,969 · 2023: $1,517 · 2024: $1,806 · 2025: $1,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,204 · Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,203.77 |
| Food and Beverage | $1,852.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Consultants | $2,038.71 | 2022-2024 | |
| Medical Device Business Services, INC. | $1,365.00 | 2020-2022 | |
| Novus Surgical Solutions LLC | $1,292.80 | 2022 | |
| Vb Spine LLC | $1,026.44 | 2025 | Everest Spinal System |
| Arthrex, INC. | $633.80 | 2023-2024 | |
| Stryker Corporation | $631.97 | 2020-2025 | Everest Spinal System, Core |
| Globus Medical, INC. | $381.99 | 2023-2024 | Reflect/Reflect Hde, Distal Femur Plate System, Excelsius3d Imaging System |
| Medacta USA, INC. | $180.20 | 2022-2024 | |
| Acumed LLC | $156.45 | 2019-2024 | Acumed |
| Kuros Biosciences USA, INC | $142.84 | 2025 | Magnetos |
| Si-Bone, INC. | $136.10 | 2021 | |
| Smith+Nephew, INC. | $114.98 | 2020 | |
| Cerapedics INC. | $93.58 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $54.53 | 2021-2025 | |
| Csl Behring | $23.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Wey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.